LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

尿颗粒分析仪与标准方法的比较

By LabMedica International staff writers
Posted on 28 Dec 2017
Print article
图片:UF-1000i自动尿颗粒分析仪(照片由Sysmex提供)。
图片:UF-1000i自动尿颗粒分析仪(照片由Sysmex提供)。
尿路感染(UTI)具有泌尿道中存在微生物病原体的特征,是住院和门诊患者中都最常出现的感染之一。大多数UTI很容易治疗。
部分患者人群,如儿童、孕妇和老年人,很容易发生并发症。观察到的UTI的症状很多,从微怒,到排尿菌血症,甚至有脓毒症。发生脓毒症时,如果诊断或治疗时机不够早,会引发死亡。
Prescient Medicine(Hummelstown,PA,USA)的医学科学家和同僚们比较了一些尿液样品产生的数据,这些尿样是从一家有572个床位的急诊护理医院收集的,收集期3个月,这些尿样保存在无菌容器中,进行了细菌培养和微生物分析。收到样品时,一份样品在5%羊血琼脂和麦康凯琼脂培养皿中培养,使用0.001毫升接种测量杯接种。
使用Sysmex UF-1000i尿液分析仪(Sysmex Corporation,Kobe,Japan)分析第二份样品的细菌和白细胞,该分析仪是一种全自动、荧光流式细胞仪,能分类计数红细胞、白细胞、上皮细胞、小圆细胞、精细胞、结晶、病理和透明管型、酵母和细菌。第二份样品还接受尿分析相关显微镜检测,查看是否有上皮细胞、白细胞、酵母和细菌。
2034份(50%)样品的尿液培养物没有细菌生长,1812份(45%)样品的集落生成单位(CFU)数量小于104。4033份结果中,754份(19%)样品细菌生长105 CFU/mL或更多,认为190份(5%)样品受到污染,因为它们含有多种细菌。但是,如果细菌生长量超出定义的阴性结果,即使UTI数量可能很低,仍认为患者样品阳性。培养阳性的样品中,最常发现的微生物是大肠埃希菌和克雷伯菌属,这与已知的流行病学数据一致。
UF-1000i检测报告中,从成人患者获得的4033份单份尿样中,2736份(67.8%)样品白细胞计数和细菌阳性,1215份(30.1%)样品白细胞计数和细菌结果阴性。该研究中成年人群任何阳性培养物的阴性预测值为95.5%,使用Sysmex UF-1000i,生长100000或更多CFU的阳性培养物的阴性预测值为99.3%。从儿科患者中收集了373份单份尿液样品,使用UF-1000i法,269份(72%)样品有白细胞计数和细菌结果阳性,104份(27.9%)样品白细胞计数升高和细菌检测结果为阴性。
作者得出结论,Sysmex UF-1000i的灵敏度为98%,专属性为93.7%,阴性预测值为95.5%。因此,使用UF-1000i进行阴性筛查,使用定义的阈值进行白细胞计数和细菌检测可能获得真阴性结果,减少了推定的抗生素使用需要。该研究发表于2017年11月刊的Archives of Pathology & Laboratory Medicine(病理学和检验医学文献)。

Related Links:
Prescient Medicine 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more